News

Corbion Concludes Share Buyback Program Successfully

Corbion Concludes Share Buyback Program Successfully

Corbion Completes Share Buyback Program

Corbion, the Amsterdam-listed company recognized for its sustainable ingredients and dedication to preservation through science, has successfully wrapped up its share buyback program initiated earlier. With a total of 577,615 ordinary shares repurchased at an average price of €17.3126, the company spent a total of €9,999,990.02.

Recent Purchases and Financial Overview

In the final week leading up to the end of the program, specifically until November 11, a total of 32,626 shares were bought back at an average price of €17.8606, costing approximately €582,721.36. This strategic move is part of Corbion's ongoing efforts to align employee incentives with long-term growth and success.

Compliance With Market Regulations

The share buyback was conducted in full accordance with the European Market Abuse Regulation, adhering to guidelines established during the Annual General Shareholders' Meeting. During this meeting, shareholders authorized the Corbion Board of Management to repurchase shares, allowing for a maximum limit of 10% of the issued share capital within a timeframe of 18 months. This careful planning reflects a commitment to transparency and accountability.

Market Communication and Reporting

Throughout the buyback period, Corbion has been diligent in keeping the market informed. Weekly press releases detailing the progress of the share buyback have been made available, showcasing a transparent approach to investor relations. For anyone interested in the execution of this program, these updates are accessible on Corbion's website.

The Impact of Share Buybacks

Share buybacks like the one conducted by Corbion help to reinforce the value of the company's stock, signaling confidence in future performance. This program not only rewards existing shareholders but also serves as a strategic tool to manage share capital efficiently. Corbion's decision is a testament to its strong financial health and commitment to its workforce.

Frequently Asked Questions

1. What was the total number of shares bought back by Corbion?

Corbion repurchased a total of 577,615 ordinary shares during its buyback program.

2. How much did Corbion spend on its share buyback program?

The total expenditure for the share buyback program was €9,999,990.02.

3. What was the average price per share for the recently purchased shares?

During the last week of the program, the average price per share was €17.8606.

4. How did the share buyback comply with regulations?

The buyback was executed in compliance with the European Market Abuse Regulation and aligned with the authorizations from the Annual General Shareholders' Meeting.

5. Where can I find updates on Corbion's share buyback program?

Updates and details about the share buyback program are available on Corbion's official website under their investor relations section.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Sales Focus Inc. Awarded as Leading Medical Outsourcing Service

Updated Category News Views 112

Sales Focus Inc.: Leading the Way in Healthcare Outsourcing Sales Focus Inc. (SFI) proudly announces its recognition as the Top Healthcare and Medical Sales Outsourcing Service for 2025. This prestigious accolade showcases the company's vital role in revolutionizing the healthcare sector with its innovative full-lifecycle sales execution model and robust industry...

Continue Reading
The Rise of Autonomous Data Platforms in the Tech Industry

Updated Category News Views 76

Exploring the Autonomous Data Platform Market Growth The world of data management is rapidly evolving, with the Autonomous Data Platform Market projected to reach an impressive USD 14.96 billion by 2032. This explosive growth expands at a significant CAGR of 27.89% from its current valuation, representing a fundamental shift in how organizations interact with their data....

Continue Reading
Enpro's Recent Insider Activity Signals Strong Future Potential

Updated Category News Views 177

Insider Purchase by William Abbey at Enpro In the latest SEC filing, the market received noteworthy news about Enpro. William Abbey, who serves as a Director at Enpro (NYSE:NPO), demonstrated significant confidence in the company by purchasing 567 shares for a total of $139,997. What This Purchase Indicates This insider transaction suggests a strong belief in Enpro's...

Continue Reading
Massive Increase in BNB Fund for Cancer Patients Unveiled

Updated Category News Views 168

BNB Donation Achieves Remarkable Growth Recently, an incredible story surfaced about the untouched donation made in BNB (CRYPTO: BNB) for cancer patients. This donation, originally valued at $200,000, has soared to an astonishing $39 million thanks to the surging market value of cryptocurrencies, particularly BNB. Impact of Cryptocurrency Fluctuation on Charity Funds...

Continue Reading
Bio X Cell Refreshes Brand Identity to Enhance Global Research Impact

Updated Category News Views 171

Bio X Cell Unveils a Fresh Brand Identity Bio X Cell, recognized as the global leader in functional antibodies tailored for in vivo and emerging preclinical models, has introduced a modernized brand identity. This change is a testament to nearly three decades of excellence in the field, seamlessly merging scientific innovation with expanding global capabilities in...

Continue Reading